Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
Patients with familial cerebral cavernous malformation (CCM) inherit germline loss of function mutations and are susceptible to progressive development of brain lesions and neurological sequelae during their lifetime. To date, no homologous circulating molecules have been identified that can reflect the presence of germ line pathogenetic CCM mutations, either in animal models or patients. We hypothesize that homologous differentially expressed (DE) plasma miRNAs can reflect the CCM germline mutation in preclinical murine models and patients. Herein, homologous DE plasma miRNAs with mechanistic putative gene targets within the transcriptome of preclinical and human CCM lesions were identified. Several of these gene targets were additionally found to be associated with CCM-enriched pathways identified using the Kyoto Encyclopedia of Genes and Genomes. DE miRNAs were also identified in familial-CCM patients who developed new brain lesions within the year following blood sample collection. The miRNome results were then validated in an independent cohort of human subjects with real-time-qPCR quantification, a technique facilitating plasma assays. Finally, a Bayesian-informed machine learning approach showed that a combination of plasma levels of miRNAs and circulating proteins improves the association with familial-CCM disease in human subjects to 95% accuracy. These findings act as an important proof of concept for the future development of translatable circulating biomarkers to be tested in preclinical studies and human trials aimed at monitoring and restoring gene function in CCM and other diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Translational stroke research - 14(2023), 4 vom: 01. Aug., Seite 513-529 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Romanos, Sharbel G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cerebral cavernous malformations |
|---|
| Anmerkungen: |
Date Completed 29.06.2023 Date Revised 20.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12975-022-01050-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34236877X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34236877X | ||
| 003 | DE-627 | ||
| 005 | 20240420232106.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12975-022-01050-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1381.xml |
| 035 | |a (DE-627)NLM34236877X | ||
| 035 | |a (NLM)35715588 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Romanos, Sharbel G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.06.2023 | ||
| 500 | |a Date Revised 20.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a Patients with familial cerebral cavernous malformation (CCM) inherit germline loss of function mutations and are susceptible to progressive development of brain lesions and neurological sequelae during their lifetime. To date, no homologous circulating molecules have been identified that can reflect the presence of germ line pathogenetic CCM mutations, either in animal models or patients. We hypothesize that homologous differentially expressed (DE) plasma miRNAs can reflect the CCM germline mutation in preclinical murine models and patients. Herein, homologous DE plasma miRNAs with mechanistic putative gene targets within the transcriptome of preclinical and human CCM lesions were identified. Several of these gene targets were additionally found to be associated with CCM-enriched pathways identified using the Kyoto Encyclopedia of Genes and Genomes. DE miRNAs were also identified in familial-CCM patients who developed new brain lesions within the year following blood sample collection. The miRNome results were then validated in an independent cohort of human subjects with real-time-qPCR quantification, a technique facilitating plasma assays. Finally, a Bayesian-informed machine learning approach showed that a combination of plasma levels of miRNAs and circulating proteins improves the association with familial-CCM disease in human subjects to 95% accuracy. These findings act as an important proof of concept for the future development of translatable circulating biomarkers to be tested in preclinical studies and human trials aimed at monitoring and restoring gene function in CCM and other diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Cerebral cavernous malformations | |
| 650 | 4 | |a Genotype | |
| 650 | 4 | |a Machine learning | |
| 650 | 4 | |a MicroRNA | |
| 650 | 7 | |a KRIT1 Protein |2 NLM | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a Circulating MicroRNA |2 NLM | |
| 700 | 1 | |a Srinath, Abhinav |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Bingqing |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Chang |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Bi, Dehua |e verfasserin |4 aut | |
| 700 | 1 | |a Sone, Je Yeong |e verfasserin |4 aut | |
| 700 | 1 | |a Lightle, Rhonda |e verfasserin |4 aut | |
| 700 | 1 | |a Hobson, Nick |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Dongdong |e verfasserin |4 aut | |
| 700 | 1 | |a Koskimäki, Janne |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Le |e verfasserin |4 aut | |
| 700 | 1 | |a McCurdy, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Catherine Chinhchu |e verfasserin |4 aut | |
| 700 | 1 | |a Stadnik, Agnieszka |e verfasserin |4 aut | |
| 700 | 1 | |a Piedad, Kristina |e verfasserin |4 aut | |
| 700 | 1 | |a Carrión-Penagos, Julián |e verfasserin |4 aut | |
| 700 | 1 | |a Shkoukani, Abdallah |e verfasserin |4 aut | |
| 700 | 1 | |a Snellings, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Shenkar, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Sulakhe, Dinanath |e verfasserin |4 aut | |
| 700 | 1 | |a Ji, Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Lopez-Ramirez, Miguel A |e verfasserin |4 aut | |
| 700 | 1 | |a Kahn, Mark L |e verfasserin |4 aut | |
| 700 | 1 | |a Marchuk, Douglas A |e verfasserin |4 aut | |
| 700 | 1 | |a Ginsberg, Mark H |e verfasserin |4 aut | |
| 700 | 1 | |a Girard, Romuald |e verfasserin |4 aut | |
| 700 | 1 | |a Awad, Issam A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Translational stroke research |d 2010 |g 14(2023), 4 vom: 01. Aug., Seite 513-529 |w (DE-627)NLM198739184 |x 1868-601X |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g number:4 |g day:01 |g month:08 |g pages:513-529 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12975-022-01050-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2023 |e 4 |b 01 |c 08 |h 513-529 | ||